W. Alberto Sifuentes Giraldo: Non-Criteria Manifestations of Antiphospholipid Syndrome
W. Alberto Sifuentes Giraldo, Rheumatologist at Hospital Nuestra Señora de Sonsoles (Sacyl), shared a post on X:
”Although the classification criteria for antiphospholipid syndrome (APS) classically require the presence of a thrombotic event in the venous vascular territory (e.g., deep vein thrombosis) or arterial territory (e.g., myocardial infarction, stroke), or recurrent fetal loss, this does not mean that patients with positive antiphospholipid antibodies who do not meet these criteria do not have this disorder.
The spectrum of APS manifestations is broad and encompasses several other symptoms that are not criteria, such as cutaneous manifestations including livedo reticularis, necrotic ulcers, pseudovasculitic lesions, digital gangrene, and splinter hemorrhages, among others.
The presence of antiphospholipid antibodies can also be associated with other symptoms, such as thrombocytopenia, valvular heart disease, epilepsy, or transverse myelitis. Furthermore, it carries an increased risk of other autoimmune disorders. In half of the cases, APS is associated with other autoimmune rheumatic diseases, the most frequent being systemic lupus erythematosus.
Non-Criteria Manifestations of Antiphospholipid Syndrome (APS). Adapted from: Pires da Rosa G, Espinosa G, Cervera R.
Non-criteria manifestations of antiphospholipid syndrome: an overview. Span J Med. 2021;1(2).”
Stay updated with Hemostasis Today.
-
Nov 2, 2026, 14:48Heghine Khachatryan: Vitamin B12 Replacement Choosing the Right Route for Each Patient
-
Nov 2, 2026, 14:28Anastasia Conti: ASH Global Research Award Backs New Directions in AML Research
-
Nov 2, 2026, 14:22Sara Zalghout: Linking Bacterial Virulence to NETosis and Thromboinflammation
-
Nov 2, 2026, 13:58Functional Iron Deficiency: From Iron Sequestration to Therapeutic Targeting
-
Nov 2, 2026, 13:56Jan Terje Andersen: Albumin Engineering Opens New Routes for Erythropoietin Delivery
-
Nov 2, 2026, 13:44Rishiraj Sinha: Strengthening ISBT–AABB Collaboration in Transfusion Medicine
-
Nov 2, 2026, 13:28Jeremiah Morris: Why Blood Detection Reagents Work Better on Dry Bloodstains
-
Nov 2, 2026, 12:38Maria Τektonidou: Machine Learning – A New Approach to CVD Risk in SLE
-
Nov 2, 2026, 12:31Toby Richards: Screening for Iron Deficiency – Nearly 1 in 4 Women Anaemic